US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Histogenics

0.1620

+0.0000

Volume:- -

Turnover:- -

Market Cap:15.33M

PE:-0.45

High:0.1620

Open:0.1620

Low:0.1620

Close:0.1620

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Histogenics

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.histogenics.com/

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Histogenics Corporation, a regenerative medicine company, focuses on developing and commercializing products in the musculoskeletal segment of the marketplace. Its product candidate includes NeoCart, which is in Phase III clinical trials, intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. The company has an exclusive channel collaboration agreement with Intrexon Corporation for the development and commercialization of allogeneic genetically modified chondrocyte cell therapeutics for the treatment or repair of damaged articular hyaline cartilage in humans. Histogenics Corporation was founded in 2000 and is headquartered in Waltham, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/HSGX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HSGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HSGX\",,,,,undefined,":{"symbol":"HSGX","market":"US","secType":"STK","nameCN":"Histogenics","latestPrice":0.162,"timestamp":1569614400000,"preClose":0.162,"halted":8,"volume":0,"delay":0,"floatShares":83530132,"shares":94599601,"eps":-0.357479,"marketStatus":"Trading","change":0,"latestTime":"04-28 13:48:57 EDT","open":0.162,"high":0.162,"low":0.162,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.357479,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1745870400000},"marketStatusCode":2,"symbolChange":{"newSymbol":"OCGN","executeDate":"2019-09-30"},"adr":0,"adrRate":0,"listingDate":1417582800000,"exchange":"NASDAQ","adjPreClose":0.162,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HSGX\",,,,,undefined,":{"symbol":"HSGX","floatShares":83530132,"roa":"-136.46%","roe":"16.69%","lyrEps":-0.23413,"shares":94599601,"dividePrice":0,"high":0.162,"amplitude":0,"preClose":0.162,"low":0.162,"week52Low":0.08,"pbRate":"-33.46","week52High":1.43,"institutionHeld":0,"latestPrice":0.162,"eps":-0.357479,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.357479,"open":0.162},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.histogenics.com/","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Histogenics Corporation, a regenerative medicine company, focuses on developing and commercializing products in the musculoskeletal segment of the marketplace. Its product candidate includes NeoCart, which is in Phase III clinical trials, intended to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. The company has an exclusive channel collaboration agreement with Intrexon Corporation for the development and commercialization of allogeneic genetically modified chondrocyte cell therapeutics for the treatment or repair of damaged articular hyaline cartilage in humans. Histogenics Corporation was founded in 2000 and is headquartered in Waltham, Massachusetts.","exchange":"NASDAQ","name":"Histogenics","nameEN":"Histogenics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"HSGX\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HSGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-09-30","symbol":"HSGX","type":"split","dateTimestamp":1569816000000,"forFactor":60,"toFactor":1,"ratio":60},{"market":"US","date":"2019-09-30","symbol":"HSGX","oldSymbol":"HSGX","newSymbol":"OCGN","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1569816000000},{"market":"US","date":"2018-11-08","symbol":"HSGX","expectedEps":-0.18,"name":"Histogenics Corporation","time":"Pre-Market","type":"earning","dateTimestamp":1541653200000,"reportTimeType":"pre","actualEps":-0.24},{"market":"US","date":"2018-08-09","symbol":"HSGX","expectedEps":-0.22,"name":"Histogenics Corporation","time":"Pre-Market","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2018-05-10","symbol":"HSGX","expectedEps":-0.07,"name":"Histogenics Corporation","time":"Pre-Market","type":"earning","dateTimestamp":1525924800000,"reportTimeType":"pre","actualEps":-0.2}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HSGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HSGX\",market:\"US\",delay:false,,,undefined,":{}}}